J&J Says Covid-19 Vaccine Batch Didn’t Meet Quality Standards

Johnson & Johnson says the batch didn’t advance to the filling and finish stages of its manufacturing process and that the quality lapse wouldn’t affect its ability to supply the U.S. with 100 million doses by the end of May.

Resorts World to Open in Las Vegas

The first new megacasino on the Strip in more than a...

Chewy CFO Says Broader Product Range Bearing Fruit in Higher Earnings

Mario Marte said pet retailer could post first net profit this...

Rising Inflation Looks Less Severe Using Pre-Pandemic Comparisons

Inflation fears loom as U.S. consumers deal with starkly higher prices...

Wage Gains at Factories Fall Behind Growth in Fast Food

Factory jobs for years paid significantly more than those in many...